Blog note: The science of genetic engineering is steadily marching forward. Once the “Restrainer” (Holy Spirit) no longer restrains the evil one, there will no longer be any ethical or moral restraint in the use of this technology. The technology is not evil. It is the hand that violates the genetic code in the pursuit of genetic corruption of the imagers of God. Studied eschatologists understand the implication of this. “In the days of Noah” God indicates that all flesh on earth (both mankind and animals) had become “corrupted”. Noah was the only one whose genetics had not become “corrupted” and was found “perfect in his generation.” The evil of lawlessness and genetic manipulation was so great that God cleaned the earth’s slate with the Great Flood. It was that bad. Yet, here we are again today. In the name of science, research and ending diseases, we search to find ways to manipulate genetics. There are two arguments; that it is good to try to find cures to diseases that result from genetic flaws. Others argue that we should not be playing “God” and messing with what God has designed. I agree strongly in favor of the “we should not be playing God” side. My concern is, that no matter how noble or well-intentioned the pursuit of genetics to solve diseases is, it will ultimately become a bastardized abomination of corruption. I’ll say it again, once the “Restrainer” (Holy Spirit) is gone, there will NOT be any moral, ethical or spiritual restraints or constraints on the evil use of genetic manipulation techniques. There will be educated, scientific people who will mock my discernment of this issue by arguing this “would never happen on their watch.” What if their life or family member’s lives were threatened if they did not work on human genetic manipulation projects? Who would possibly threaten them? and why? What could the real world consequences be from un-naturally manipulating the human genome? I am not a genetic scientist (although I am a data scientist). The potential genetic abominations could only be abhorrent. God seems to think so since he had to wipe the earth clean once before. End of note.
GENE THERAPY COULD BECOME AS EASY TO GET AS A FLU SHOT
KRISTIN HOUSER. October 24, 2018. futurism.com
Genetic engineering research is time-consuming and cost-prohibitive. If we want gene editing to help us all live longer, healthier lives, we need to streamline the process.
That’s Synthego’s stance, anyway.
The startup asserts that genetic engineering research is both time-consuming and cost-prohibitive, and it believes those characteristics are slowing down progress in the field. To address the issue, it sells engineered cells and CRISPR kits to researchers. This reportedly saves those researchers both time and money, and now, Synthego has an additional $110 million with which to further develop its technologies.
On Tuesday, Synthego announced it closed a $110 million investment round. Leading the investment was Founders Fund, a venture capital firm that was an early backer of SpaceX and Facebook. As you’d expect, the language of the announcement is a cross between medical terminology and the lingo of a Silicon Valley startup.
“This new funding allows us to expand our reach and build out our full stack platform capabilities at a perfect time,” said Synthego CEO Paul Dabrowski in a press release. “Biological medicines are on the cusp of a revolution with the coming curative cell and gene therapies, and we are proud to support this industry.”
CRISPR For All
Helping scientists conduct gene editing research is just one part of the equation, though — Synthego is also very concerned about how the gene therapies developed today will affect the lives of people tomorrow.
“The headlines around genome editing make it sound simple, but the reality is that bringing laboratory discoveries to humans is a complex process requiring specialized expertise, reagents, and commitment,” Synthego advisory board member Matthew Porteus said in the release. Synthego is hopeful that the technologies it develops now will help democratize access to those therapies. According to Dabrowski, “Our vision is a future where cell and gene therapies are ultimately as accessible as vaccines, so that everyone can benefit from next-generation cures.”